How reliable are direct-to-consumer genetic tests when interpreting cancer risk? 22 Feb 2022 At-home genetic testing has gained a lot of traction in recent years, raising many ethical issues. Diana Cano talked to world-leading cancer genetics expert Professor Ros Eeles to find out more about the promises and dangers of direct-to-consumer tests in helping to manage cancer risk. Find out more Show/Hide
A targeted prostate cancer screening programme could be possible in five years - what will it look like? 28 Jan 2022 The UK began screening for breast cancer nearly 35 years ago but we’re yet to have a screening programme for prostate cancer. Julia Bakker spoke to the UK’s leading expert in prostate cancer genetics, the ICR’s Professor Ros Eeles, about the progress we’re making and when we can expect prostate cancer screening to be a reality. Find out more Show/Hide
DNA Day: How we’re turning the tables on cancer 25 Apr 2021 DNA damage is the underlying cause of cancer – but it is also a key weakness in cancer cells that can be exploited for treatment. This DNA Day, we highlight scientists at the Institute of Cancer Research who are exploring how cancer cells repair damage to their DNA to understand more about how cancers develop, and to uncover new ways to treat the disease. Find out more Show/Hide